# LSU HEALTH SCIENCES CENTER: Next generation oncolytic virotherapy targeting AKT and ERK signaling in glioma

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | LSU HEALTH SCIENCES CENTER |
| Location | NEW ORLEANS, LA |
| Project | Next generation oncolytic virotherapy targeting AKT and ERK signaling in glioma |
| Project number | 7R01NS137577-03 |
| Mechanism | R01 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $577,220 |
| Awarded | 2026-09-01 |
| Project period | 2024-05-10 to 2029-04-30 |
| UEI | M7KCJ79FAVH5 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11578987). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.